SerpinA3N deficiency deteriorates impairments of learning and memory in mice following hippocampal stab injury.
Zhi-Meng WangCong LiuYing-Ying WangYu-Sen DengXuan-Cheng HeHong-Zhen DuChang-Mei LiuZhao-Qian TengPublished in: Cell death discovery (2020)
Traumatic brain injury is a global leading cause of disability and death, which puts patients at high risk for developing dementia. Early intervention is believed as the key to minimize the development of brain damages that could aggravate the symptoms. Here, we report that the serine protease inhibitor SerpinA3N is upregulated in hippocampal neurons in the early stage of hippocampal stab injury (HSI), while its deficiency causes a greater degree of neuronal apoptosis and severer impairments of spatial learning and memory in mice after HSI. We further show that MMP2 is a key substrate of SerpinA3N, and MMP2 specific inhibitor (ARP100) can protect against neuronal apoptosis and cognitive dysfunction in mice after HSI. These findings demonstrate a critical role for SerpinA3N in neuroprotection, suggesting that SerpinA3N and MMP2 inhibitors might be a novel therapeutic agents for neurotrauma.
Keyphrases
- cerebral ischemia
- traumatic brain injury
- early stage
- high fat diet induced
- subarachnoid hemorrhage
- oxidative stress
- randomized controlled trial
- end stage renal disease
- endoplasmic reticulum stress
- blood brain barrier
- brain injury
- cell cycle arrest
- cell death
- mild cognitive impairment
- ejection fraction
- newly diagnosed
- cell migration
- spinal cord
- chronic kidney disease
- prognostic factors
- multiple sclerosis
- cognitive impairment
- physical activity
- replacement therapy
- peritoneal dialysis
- radiation therapy
- insulin resistance
- signaling pathway
- amino acid
- spinal cord injury
- lymph node